Iran is offering more flexible terms on oil price fluctuations and investment risks to make the sector attractive, the Financial Times reports.» Read More
India's industrial output shrank in November after a spurt the previous month, denting hopes of a recovery in economic growth and strengthening the case for an interest rate cut later this month.
Neil Atkinson, director of energy research and analysis at Datamonitor, tells CNBC he is not surprised that the U.S. federal government has banned BP from winning new federal contracts.
The average U.S. home value is $147,300, but a professional athlete's home is anything but average. Read ahead to see 10 of the coolest athlete homes on the market.
Liberty Media's John Malone is making an effort to take control of Sirius XM Radio, and the company's boss Mel Karmazin is trying to prevent it. CNBC's David Faber reports on the details.
For some, feuds are as integral to spectator sports as the game itself. Read ahead to see which recent sports feuds have been exciting, thrilling and explosive.
Discussing whether Apple could break new highs in 2012, even as it hit $403/share today, with Jeff Fidarco, Susquehanna Financial.
Who are some professional athlete fathers whose sons followed in their footsteps? Find out!
However long they were married, the price of breaking the contract was huge -- sometimes even reached nine figures.
What are some of the most notable multimillion-dollar sports injuries? Check out the list.
CNBC's Sue Herera has the story on a strike issued for three southern California supermarkets: Ralphs, Vons, and Albertons.
Shares of the online movie company dropped after failing to reach a new content deal with Starz. Michael Olson, Piper Jaffray weighs in.
What are some of the sports contracts that had terrible consequences for the teams that wrote them? Click and find out.
Airbus is flying high after scoring a record number of orders at the Paris Air Show, with CNBC's Phil LeBeau.
The chairman of the House Oversight and Government Reform Committee told CNBC that he wants to know whether political considerations drove the government’s decision to steer a potentially multibillion-dollar contract to a company in which financier Ron Perelman's investment firm has a significant stake.
Financier Ron Perelman’s entry into the smallpox antiviral medicine business has led to a congressional investigation, CNBC has learned.
CNBC's Eamon Javers has the story on who got a multi-billion dollar, no-bid contract, and whether political influence was at play.